Shinie L Kuo, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Hospitals listed: Kaiser Foundation Hospital-San Jose. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kuo’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-San JoseSan Jose, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-San Jose
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.22 to 2.37) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.43 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 271 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 2,952 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.04 to 0.5) · 894 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 908 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.19 (0.67 to 5.72) · 176 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 61 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.53 to 3.92) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.11 (0 to 17.58) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.53) · 630 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 48 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.843 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.88 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.611 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 171 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 571 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 147.1 · 28 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 21 · 639 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 157 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,294 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 61% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$3,827
Medicare paid this office $3,827 for 78 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 54 | $448 | $7 |
Who their Medicare patients are
78 Original Medicare patients in 2024. Average age 73 · Under 65 15% · 85 and older 17% · Women 45% · Also on Medicaid 54% · Health risk score 2.37. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 55% · Chronic kidney disease 44% · Atrial fibrillation 41% · Heart failure 40% · Coronary heart disease 32% · Dementia 24% · Stroke 21% · COPD 18% · Depression 17%.
The office billed $17,508, Medicare allowed $5,007 and paid $3,827; for 107 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 78 | 107 | 73 | 2.37 | $17,508 | $3,827 |
| 2023 | 100 | 145 | 71 | 2.26 | $21,282 | $4,907 |
| 2022 | 73 | 99 | 69 | 2.50 | $17,358 | $3,521 |
| 2021 | 70 | 110 | 72 | 2.72 | $12,169 | $2,709 |
| 2020 | 52 | 87 | 64 | 2.59 | $6,809 | $1,777 |
| 2019 | 90 | 135 | 69 | 2.69 | $10,386 | $2,262 |
| 2018 | 118 | 168 | 70 | 3.04 | $13,450 | $3,116 |
| 2014 | 91 | 92 | 67 | 3.01 | $36,672 | $14,089 |
| 2013 | 116 | 119 | 68 | 2.77 | $44,878 | $17,436 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $846 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 72 | $665 | $7 |
2022: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $707 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 51 | $465 | $7 |
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 53 | $519 | $7 |
2020: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 47 | $422 | $7 |
2019: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 76 | $760 | $7 |
2018: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $974 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 88 | $760 | $7 |
2014: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $10,727 | $163 |
2013: 3 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $13,022 | $165 |
| Initial hospital observation care per day, typically 70 minutes | 12 | $1,798 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,374 | $81 |
Medicaid work
$5,034 in 2024
Medicaid paid $5,034 for 530 billed services this clinician did in 2024, up to 97 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 530 | $5,034 |
| 2024 | 530 | 1 | 97 | $5,034 |
| 2023 | 517 | 1 | 86 | $912 |
| 2022 | 329 | 3 | 54 | $709 |
| 2021 | 199 | 1 | 38 | $501 |
| 2020 | 232 | 1 | 45 | $484 |
| 2019 | 299 | 1 | 36 | $752 |
| 2018 | 212 | 1 | 38 | $594 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 517 | $912 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 304 | $522 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $187 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13 | $0 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 199 | $501 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 232 | $484 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 299 | $752 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 212 | $594 |
Drugs they prescribed that Part D paid
$149,841
Pharmacies billed $149,841 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,024) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
838 generic and 186 brand-name prescriptions · $149,841 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 72 | $71,334 | $991 |
| Jardiance | 50 | $23,446 | $469 |
| Xarelto | 14 | $11,623 | $830 |
| Pradaxa | 34 | $8,587 | $253 |
| Flecainide Acetate | 55 | $2,207 | $40 |
See all 22 drugs
| Entresto | 72 | $71,334 | $991 |
| Jardiance | 50 | $23,446 | $469 |
| Xarelto | 14 | $11,623 | $830 |
| Pradaxa | 34 | $8,587 | $253 |
| Flecainide Acetate | 55 | $2,207 | $40 |
| Amiodarone | 91 | $2,129 | $23 |
| Metoprolol | 103 | $1,277 | $12 |
| Furosemide | 76 | $1,023 | $13 |
| Ranolazine Er | 27 | $950 | $35 |
| Atorvastatin | 75 | $843 | $11 |
| Spironolactone | 52 | $546 | $11 |
| Metoprolol | 59 | $534 | $9 |
| Diltiazem 24hr Er (Cd) | 16 | $504 | $32 |
| Rosuvastatin | 44 | $482 | $11 |
| Losartan | 38 | $420 | $11 |
| Sotalol | 13 | $403 | $31 |
| Amlodipine Besylate | 32 | $380 | $12 |
| Carvedilol | 24 | $322 | $13 |
| Isosorbide Mononitrate Er | 17 | $281 | $17 |
| Nitroglycerin | 17 | $192 | $11 |
| Atenolol | 11 | $158 | $14 |
| Ezetimibe | 12 | $140 | $12 |
Year by year
| 2024 | 1,024 | 245 | 0% (0) | 18% | $149,841 |
| 2023 | 1,033 | 303 | None | 21% | $196,262 |
| 2022 | 788 | 220 | 0% (0) | None | $135,330 |
| 2021 | 568 | 150 | 0% (0) | 23% | $232,756 |
| 2020 | 412 | 139 | 0% (0) | 16% | $38,499 |
| 2019 | 434 | 135 | 0% (0) | 23% | $45,252 |
| 2018 | 340 | 142 | 0% (0) | 30% | $27,500 |
| 2017 | 303 | 75 | 0% (0) | 21% | $44,476 |
| 2016 | 242 | 71 | 0% (0) | 26% | $24,524 |
| 2015 | 81 | 30 | 0% (0) | 19% | $4,128 |
| 2013 | 71 | 25 | None | 21% | $4,296 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Entresto | 83 | $71,786 | $865 |
| Jardiance | 39 | $25,792 | $661 |
| Xarelto | 13 | $13,782 | $1,060 |
| Pradaxa | 37 | $9,671 | $261 |
| Amiodarone | 84 | $2,109 | $25 |
| Flecainide Acetate | 52 | $2,000 | $38 |
| Potassium Chloride | 16 | $1,471 | $92 |
| Metoprolol | 82 | $1,258 | $15 |
| Diltiazem 24hr Er (Cd) | 27 | $876 | $32 |
| Furosemide | 68 | $847 | $12 |
| Rosuvastatin | 41 | $690 | $17 |
| Metoprolol | 66 | $661 | $10 |
| Spironolactone | 58 | $594 | $10 |
| Losartan | 48 | $594 | $12 |
| Isosorbide Mononitrate Er | 20 | $563 | $28 |
| Amlodipine Besylate | 36 | $527 | $15 |
| Ranolazine Er | 12 | $435 | $36 |
| Atorvastatin | 36 | $430 | $12 |
| Carvedilol | 25 | $321 | $13 |
| Sotalol | 13 | $312 | $24 |
| Nitroglycerin | 19 | $267 | $14 |
| Clopidogrel | 11 | $220 | $20 |
| Atenolol | 13 | $198 | $15 |
| Cephalexin | 21 | $149 | $7 |
| Ezetimibe | 13 | $147 | $11 |
| Lisinopril | 11 | $132 | $12 |
2022: 19 drugs
| Entresto | 89 | $66,793 | $750 |
| Eliquis | 11 | $17,377 | $1,580 |
| Pradaxa | 25 | $13,121 | $525 |
| Jardiance | 12 | $7,172 | $598 |
| Amiodarone | 70 | $2,013 | $29 |
| Rosuvastatin | 41 | $1,378 | $34 |
| Flecainide Acetate | 24 | $1,016 | $42 |
| Metoprolol | 62 | $990 | $16 |
| Isosorbide Mononitrate Er | 34 | $871 | $26 |
| Diltiazem 24hr Er (Cd) | 27 | $756 | $28 |
| Furosemide | 44 | $568 | $13 |
| Atorvastatin | 43 | $538 | $13 |
| Carvedilol | 32 | $445 | $14 |
| Metoprolol | 42 | $421 | $10 |
| Sotalol | 13 | $387 | $30 |
| Amlodipine Besylate | 26 | $350 | $13 |
| Spironolactone | 33 | $331 | $10 |
| Losartan | 24 | $273 | $11 |
| Lisinopril | 13 | $148 | $11 |
2021: 16 drugs
| Entresto | 34 | $25,002 | $735 |
| Eliquis | 16 | $22,563 | $1,410 |
| Pradaxa | 16 | $10,809 | $676 |
| Rosuvastatin | 31 | $932 | $30 |
| Flecainide Acetate | 26 | $756 | $29 |
| Metoprolol | 44 | $745 | $17 |
| Amiodarone | 26 | $714 | $27 |
| Furosemide | 46 | $555 | $12 |
| Atorvastatin | 42 | $519 | $12 |
| Ezetimibe | 13 | $481 | $37 |
| Metoprolol | 45 | $450 | $10 |
| Carvedilol | 37 | $436 | $12 |
| Isosorbide Mononitrate Er | 32 | $388 | $12 |
| Losartan | 17 | $232 | $14 |
| Spironolactone | 20 | $167 | $8 |
| Lisinopril | 12 | $154 | $13 |
2020: 13 drugs
| Eliquis | 14 | $11,754 | $840 |
| Metoprolol | 29 | $560 | $19 |
| Flecainide Acetate | 18 | $514 | $29 |
| Atorvastatin | 33 | $478 | $14 |
| Carvedilol | 38 | $455 | $12 |
| Amiodarone | 14 | $447 | $32 |
| Metoprolol | 40 | $413 | $10 |
| Rosuvastatin | 24 | $405 | $17 |
| Isosorbide Mononitrate Er | 14 | $318 | $23 |
| Furosemide | 24 | $279 | $12 |
| Spironolactone | 20 | $221 | $11 |
| Losartan | 17 | $220 | $13 |
| Amlodipine Besylate | 13 | $158 | $12 |
2019: 14 drugs
| Eliquis | 14 | $10,609 | $758 |
| Pradaxa | 14 | $6,618 | $473 |
| Atorvastatin | 39 | $1,046 | $27 |
| Dilt-Xr | 12 | $1,001 | $83 |
| Metoprolol | 23 | $756 | $33 |
| Amiodarone | 21 | $540 | $26 |
| Carvedilol | 47 | $538 | $11 |
| Rosuvastatin | 17 | $412 | $24 |
| Ezetimibe | 12 | $351 | $29 |
| Furosemide | 28 | $340 | $12 |
| Metoprolol | 32 | $327 | $10 |
| Losartan | 18 | $245 | $14 |
| Spironolactone | 18 | $228 | $13 |
| Isosorbide Mononitrate Er | 14 | $224 | $16 |
2018: 13 drugs
| Eliquis | 11 | $5,048 | $459 |
| Pradaxa | 11 | $3,097 | $282 |
| Metoprolol | 19 | $1,134 | $60 |
| Dilt-Xr | 16 | $810 | $51 |
| Atorvastatin | 28 | $645 | $23 |
| Rosuvastatin | 11 | $402 | $37 |
| Amiodarone | 16 | $343 | $21 |
| Carvedilol | 27 | $297 | $11 |
| Losartan | 18 | $271 | $15 |
| Metoprolol | 24 | $269 | $11 |
| Furosemide | 21 | $244 | $12 |
| Lisinopril | 14 | $168 | $12 |
| Spironolactone | 11 | $105 | $10 |
2017: 9 drugs
| Eliquis | 15 | $9,653 | $644 |
| Ezetimibe | 20 | $8,110 | $406 |
| Rosuvastatin | 35 | $3,172 | $91 |
| Metoprolol | 14 | $685 | $49 |
| Atorvastatin | 29 | $225 | $8 |
| Carvedilol | 19 | $131 | $7 |
| Lisinopril | 18 | $111 | $6 |
| Metoprolol | 18 | $74 | $4 |
| Furosemide | 15 | $30 | $2 |
2016: 5 drugs
| Atorvastatin | 67 | $850 | $13 |
| Isosorbide Mononitrate Er | 12 | $342 | $28 |
| Metoprolol | 11 | $277 | $25 |
| Carvedilol | 14 | $57 | $4 |
| Furosemide | 12 | $29 | $2 |
2015: 2 drugs
| Metoprolol | 11 | $298 | $27 |
| Atorvastatin | 21 | $255 | $12 |
2013: 1 drug
| Levetiracetam | 13 | $183 | $14 |
Money from drug and device companies
$42 in 2025
| 2025 | 1 | 1 | None | $42 |
| 2019 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotronik | Amvia Edge | $42 | 1 payment
|
See the published payment
| Biotronik | Meals · 2025-11-07 | Amvia Edge | $42 |
See earlier years (2019)
2019: $16
| HeartFlow | None | $16 | 1 payment
|
Professional record
- NPI
- 1811218035
- Licence
- MI 4301096831
- Trained
- University of California, Davis School of Medicine, 2010
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 3621 S State St, 700 Kms Place, Ann Arbor, MI, 48108
- NPI first listed
- 2010-06-22
- NPI last updated
- 2022-01-10
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.